Brief: Unicycive Therapeutics: Regained Compliance With Minimum Market Value Requirement - SEC Filing
25/09/2024 11:08
Sept 25 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE THERAPEUTICS INC SAYS ON SEPT 24, RECEIVED
NOTICE FROM
NASDAQ CO REGAINED COMPLIANCE WITH MINIMUM MARKET VALUE
REQUIREMENT - SEC FILING
Source text for Eikon: ID:n0001213900-24-081531
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss